LOGO
pl en

Urological aspect of pelvic exenteration for gynecologic oncologic indications

Tomasz Drewniak1, Marta Stelmach2, Kazimierz Pityński2, Andrzej Stelmach1

Affiliacja i adres do korespondencji
Curr Gynecol Oncol 2019, 17 (4), p. 178–184
DOI: 10.15557/CGO.2019.0023
Streszczenie

Endometrial and cervical cancers belong to the most common neoplasms in women. Surgery is the primary treatment approach and may be combined with other methods, such as radiation or systemic therapy, if needed. Despite radical primary treatment, recurrence or disease progression may occur is some patients. Although the management is relatively simple and associated with lower mortality and complication rates in patients with early stage cancer, surgical treatment of advanced and recurrent tumors is much more complex and often requires extensive procedures. Pelvic exenteration involves removal of part or all of the pelvic organs. In the case of cancer that persists or recurs after primary treatment, the surgery is difficult and usually associated with high rates of postoperative complications and higher perioperative mortality. However, it gives patients a chance to survive, which may be impossible without surgical intervention. It can alleviate the symptoms of the underlying disease in carefully selected patients. Pelvic exenteration is performed in two stages: resection and reconstruction. During reconstruction, gastrointestinal and urinary tract continuity is reestablished, and the mode of reconstruction differs depending on many factors, especially in the case of the urinary tract, which will be discussed in this paper.

Słowa kluczowe
exenteration, lesser pelvis, cervical cancer